The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Disturbances Of DNA Regulation In Obesity, And Their Relationships To Metabolic Health
Funder
National Health and Medical Research Council
Funding Amount
$354,074.00
Summary
We have shown there exists significant differences in methylation patterns between Obese patients and healthy controls. In this study we will refine our understanding of the relationship between methylation and obesity. Our study will provide insight into how methylation changes observed in obesity influence downstream metabolic disorders such as diabetes and cardiovascular disease.
Protective Mechanisms Of MAP Kinase Phosphatase 5 In Adipose Tissue Fibrosis, Hepatic Steatosis And Atherosclerosis
Funder
National Health and Medical Research Council
Funding Amount
$352,729.00
Summary
Obesity and associated complications such as diabetes, non-alcoholic fatty liver disease and atherosclerosis are a serious health burden. Recently, we found that MKP5, a molecule that restricts intracellular signaling, plays a central role in preventing these diseases. This collaborative project will elucidate how precisely MKP5 acts and explore how this molecule can be targeted for the development of novel therapeutic strategies in prevention and treatment of human metabolic diseases.
Sleep-wake Disturbances And Cardio-metabolic Dysfunction In At Risk Dementia: A Novel Pathway In Neurocognitive Decline’
Funder
National Health and Medical Research Council
Funding Amount
$558,305.00
Summary
Age-related sleep and circadian disturbance and cardio-metabolic dysfunction are associated with an increased risk of dementia. This research aims to delineate the pathway in which sleep and circadian disturbances and cardio-metabolic dysfunction promote cognitive decline during the ‘at risk’ dementia phase. This will improve our understanding of key processes in cognitive ageing ultimately leading to the development of targeted intervention programs in the quest to delay the onset of dementia.
Long-term Outcome Of Individuals Who Had A First-episode Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$1,344,905.00
Summary
The long-term illness course and outcomes of patients treated for first episode psychosis are poorly understood especially in terms of important domains such as social and vocational functioning, physical health, and quality of life. This treated cohort study of a sample of 786 patients, 15 years after their first episode of psychosis will be one of the longest and largest conducted to date. Results of the study will inform clinical practice and policy development.
Early Nutrition, Epigenetics And Developmental Outcomes In Children.
Funder
National Health and Medical Research Council
Funding Amount
$550,093.00
Summary
Increasing evidence demonstrates that early nutrition, including in pregnancy, has long lasting programming effects on later health of children. Evidence implicates epigenetics (literally ‘above DNA’) in mediating these effects. The most convincing data exists for obesity and related disorders such as metabolic syndrome, diabetes, and heart disease. The focus of this project is on understanding how ‘epigenetic’ mechanisms are influencing the way our genes function to cause these disorders.
PSYSCAN— Translating Neuroimaging Findings From Research Into Clinical Practice
Funder
National Health and Medical Research Council
Funding Amount
$376,285.00
Summary
Our ability to predict the onset and outcome of schizophrenia and other psychotic disorders remains limited. This restricts the implementation of effective preventative and early interventions. This project will rectify this by developing a tool of significant clinical utility. The project has 2 aims: 1. To develop and validate a neuroimaging-based tool for use in early psychosis to assist with early diagnosis, outcome, and disease progression. 2. To apply the tool in clinical practice.
Targeting G-quadruplex DNA As A Novel Therapeutic Strategy For Alzheimer’s And Frontotemporal Dementia
Funder
National Health and Medical Research Council
Funding Amount
$720,144.00
Summary
Dementia is the third leading cause of death in Australia and there is an urgent need to identify new ways of treating diseases that cause dementia. Our research is focused on targeting an unusual DNA structure in Alzheimer’s and Frontotemporal dementia (FTD). We will use a precision-targeted technology to better control formation of this DNA structure in disease-causing genes, allowing us to switch off the gene and hence stop disease progression for Alzheimer’s and FTD.
Modifiable Risk Factors For Serious Mental Illness - An Integrated Program Of Epidemiology, Genetics And Clinical Trials
Funder
National Health and Medical Research Council
Funding Amount
$3,750,000.00
Summary
John McGrath has discovered that vitamin D during brain development is associated with psychosis. Just as the use of folate decreased the incidence of spina bifida, vitamin D supplementation could decrease the incidence of psychosis. Using international samples, McGrath will search for modifiable risk factors for mental illness related to nutrition, infection and stress. He will use the latest methods from genetics to explore modifiable risk factors and undertake clinical trials.
Personalised Prognostic Tools For Early Psychosis Management (PRONIA)
Funder
National Health and Medical Research Council
Funding Amount
$401,739.00
Summary
Psychosis can be a devastating illness with harmful long-term consequences, such as chronic schizophrenia. To avoid distress, deterioration, and potential disability, we need more accurate tools to personalise treatment for individuals by understanding their prognosis. The PRONIA project will help to improve methods of predicting outcomes by working with our European colleagues to create a cybernetic prognostic system for psychosis that uses brain imaging, genetics, cognition, and clinical marke ....Psychosis can be a devastating illness with harmful long-term consequences, such as chronic schizophrenia. To avoid distress, deterioration, and potential disability, we need more accurate tools to personalise treatment for individuals by understanding their prognosis. The PRONIA project will help to improve methods of predicting outcomes by working with our European colleagues to create a cybernetic prognostic system for psychosis that uses brain imaging, genetics, cognition, and clinical markers.Read moreRead less
Bacterial Metabolite Mediated Regulation Of The Immune And Metabolic Systems
Funder
National Health and Medical Research Council
Funding Amount
$303,374.00
Summary
The cellular and molecular events that underpin metabolic syndrome diseases, such as diabetes, fatty liver, etc are poorly understood. However recent advances provide new clues. First, the immune system is intimately connected to metabolism. Second, the gut microbiota, and its metabolites such as acetate and butyrate are also important. These metabolites induce epigenetic changes in cells. We will study how metabolites induce molecular changes epigenetically, and how this controls metabolism.